Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Metastatic Colorectal Cancer, Colorectal Cancer

In brief

The purpose of this study is to evaluate whether therapy with MORAb-004 is effective and safe in the treatment of metastatic, colorectal cancer.

Key facts

Study ID

NCT01507545

Run by

Morphotek

People needed

154

Starts

2012-03-27

Expected to finish

2013-10-20

Last updated by the study team

2022-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females >18 years old
• Diagnosis of metastatic, colorectal cancer
• Significant medical conditions must be well-controlled and stable for at least 30 days prior to the first treatment infusion
• Be willing and able to provide written informed consent

You may not qualify if…

• No prior treatment for metastatic colorectal cancer
• Other serious systemic diseases (bacterial or fungal)
• Clinically significant heart disease or an arrhythmia on an ECG within the past 6 months
• Known allergic reaction to monoclonal antibody therapy

Where it is running

• Comprehensive Blood and Cancer Center — Bakersfield, California, United States
• Providence St. Joseph Medical Center-Disney Family Cancer Center — Burbank, California, United States
• St. Jude Heritage Healthcare — Fullerton, California, United States
• The Thomas and Dorothy Leavey Cancer Center Northridge Hospital Medical Center — Northridge, California, United States
• UC Davis Comprehensive Cancer Center — Sacramento, California, United States
• Sharp Memorial Hospital — San Diego, California, United States
• CPMCRI / Pacific Hematology Oncology Associates — San Francisco, California, United States
• Central Coast Medical Oncology — Santa Maria, California, United States
• UCLA Hematology Oncology — Santa Monica, California, United States
• Colorado Cancer Research Program — Denver, Colorado, United States
• St. Mary's Hospital Regional Cancer Center — Grand Junction, Colorado, United States
• Lutheran Hematology & Oncology — Wheat Ridge, Colorado, United States
• Christiana Care Health Services — Newark, Delaware, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Mayo Clinic Florida Hematology/Oncology — Jacksonville, Florida, United States
• Integrated Community Oncology Network / Cancer Specialists of North Florida — Jacksonville, Florida, United States
• Compass Research, LLC — Orange City, Florida, United States
• Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida, United States
• Cancer Care Centers of Brevard — Rockledge, Florida, United States
• H. Lee Moffitt Cancer Center (Moffitt Cancer Center) — Tampa, Florida, United States
• Suburban Hematology-Oncology Associates, P.C. — Duluth, Georgia, United States
• Suburban Hematology-Oncology Assoc., PC — Lawrenceville, Georgia, United States
• Suburban Hematology-Oncology Associates, P.C. — Snellville, Georgia, United States
• Medical and Surgical Specialists — Galesburg, Illinois, United States
• Central Hem/Onc Medical Group, Inc. — Alhambra, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.